Article
Phosphoproteomics identifies PI3K inhibitor-selective adaptive responses in pancreatic…
bioRxiv · 2021 · C Cintas
Key facts
| Title | Phosphoproteomics identifies PI3K inhibitor-selective adaptive responses in pancreatic cancer cell therapy and resistance |
|---|---|
| First author | C Cintas |
| Journal | bioRxiv |
| Published | May 10, 2021 |
| DOI | 10.1101/2020.10.08.313833 |
| Devices mentioned | K183375 |
| Product codes mentioned | JJE |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1